TransMedics (TMDX) Preferred Stock Liabilities (2018 - 2019)
TransMedics' (TMDX) quarterly Preferred Stock Liabilities came in at $186.5 million in Q1 2019, little changed quarter-over-quarter from $186.5 million in Q4 2018.
TransMedics (TMDX) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends
TransMedics' Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $186.5 million for Q1 2019.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $186.5 million in Q1 2019; TTM through Mar 2019 was $186.5 million, a N/A change from a year earlier, with the FY2018 full-year figure at $186.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities steadied at $186.5 million in Q1 2019 per TMDX's latest filing, from $186.5 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $186.5 million in Q4 2018 and bottomed at $186.5 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TransMedics | 2.45 Bn | 1.98 Bn | 101.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2019 | 186.52 Mn |
| Dec 29, 2018 | 186.52 Mn |